by University of Oxford Credit: CC0 Public Domain Researchers from the University of Oxford have today reported new findings from a Phase 1 clinical trial studying the immune response and safety of their newly-developed single shot rabies vaccine, ChAdOx2 RabG—with promising results identified. The RAB001 trial was conducted at the University and is the first...
